Pharmabiz

Pondicherry DC dept mandates 100% batch testing to combat counterfeit medicines

Pondicherry DC dept mandates 100% batch testing to combat counterfeit medicines: Peethaambaran Kunnathoor, Chennai Friday, ...
Pharmabiz

AiMeD asks Centre to raise import tariffs from 7.5% to 10-15% to boost domestic manufacturing of medical devices

Gireesh Babu, New Delhi Friday, January 9, 2026, 08:00 Hrs [IST] ...
Pharmabiz

Basilea Pharmaceutica inks agreement with Prokaryotics to develop a novel broad-spectrum antifungal to treat severe invasive infections

Allschwil, Switzerland Friday, January 9, 2026, 13:00 Hrs [IST] ...
Pharmabiz

Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting

Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting: Our Bureau, Bengaluru Friday, January 9, 2026, 12:15 Hrs [IST] Shilp ...
Pharmabiz

Ascentage Pharma receives US FDA’s IND clearance for BTK degrader APG-3288 to treat patients with relapsed/refractory B-cell malignancies

Ascentage Pharma receives US FDA’s IND clearance for BTK degrader APG-3288 to treat patients with relapsed/refractory B-cell malignancies: Rockville, Maryland Friday, January 9, ...
Pharmabiz

Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC

Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC: Rahway, New Jersey Friday, January 9, 2026, 15:00 Hrs [IST] ...
Pharmabiz

Inizio Ignite sparks a new era of connected advisory solutions to accelerate pharmaceutical performance

Inizio Ignite sparks a new era of connected advisory solutions to accelerate pharmaceutical performance: Chicago Friday, January 9, 2026, 18:00 Hrs [IST] Inizio, a leading global ...
Pharmabiz

UK MHRA approves Nirogacestat hydrobromide to treat desmoid tumours

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has on 7th January, 2026 approved the medicine Nirogacestat hydrobromide (Ogsiveo) for the treatment of progressing desmoid tumours in ...
Pharmabiz

Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data

Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data: Stockholm Friday, January 9, 2026, 11:00 Hrs [IST] Sobi, a global biopharma company, anno ...
Pharmabiz

Bayer & Soufflé Therapeutics enter strategic collaboration to advance cell-specific heart-targeted siRNA therapy

Bayer & Soufflé Therapeutics enter strategic collaboration to advance cell-specific heart-targeted siRNA therapy: Berlin, Germany Friday, January 9, 2026, 09:00 Hrs [IST] Bayer a ...
Pharmabiz

Cardio Diagnostics, Aimil & Dr Lal PathLabs partner to introduce PrecisionCHD test in India

Cardio Diagnostics, Aimil & Dr Lal PathLabs partner to introduce PrecisionCHD test in India: Our Bureau, Mumbai Friday, January 9, 2026, 11:15 Hrs [IST] Cardio Diagnostics Holding ...
Pharmabiz

Sharp Sterile Manufacturing increases production capacity with $28 million investment

Sharp Sterile Manufacturing increases production capacity with $28 million investment: Lee, Massachusetts Friday, January 9, 2026, 16:00 Hrs [IST] Sharp Sterile Manufacturing, a l ...